Molecular genetics of exercise-induced polymorphic ventricular tachycardia: Identification of three novel cardiac ryanodine receptor mutations and two common calsequestrin 2 amino-acid polymorphisms

European Journal of Human Genetics

Volumn 11, Issue 11, 2003, Pages 888-891

  Laitinen, Päivi J ^a   Swan, Heikki ^b   Kontula, Kimmo ^a,b  

^a Biomedicum Helsinki ^*  (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Calsequestrin; Mutation; Polymorphism; Ryanodine receptor; Ventricular arrhythmia

Indexed keywords

AMINO ACID; CALCIUM; CALSEQUESTRIN; DNA; RYANODINE RECEPTOR;

ALLELE; ARTICLE; BLOOD DONOR; CALCIUM SIGNALING; CATECHOLAMINERGIC SYSTEM; CONTROLLED STUDY; DNA POLYMORPHISM; EXERCISE; FAMILY; GENE MUTATION; GENETIC IDENTIFICATION; GENETIC LINKAGE; GENETIC SCREENING; GENOTYPE; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; MOLECULAR GENETICS; PRIORITY JOURNAL;

ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CALSEQUESTRIN; CHILD, PRESCHOOL; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; EXERCISE; FEMALE; FINLAND; HUMANS; LONG QT SYNDROME; MALE; MUTATION, MISSENSE; PEDIGREE; POLYMORPHISM, GENETIC; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; TACHYCARDIA, VENTRICULAR;

EID: 0242609817     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201061     Document Type: Article

References (20)

1. Swan H, Piippo K, Viitasalo M et al: Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol 1999; 34: 2035-2042.
2. Laitinen PJ, Brown KM, Piippo K et al: Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001; 103: 485-490.
3. Priori SG, Napolitano C, Tiso N et al: Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001; 103: 196-200.
4. Tiso N, Stephan DA, Nava A et al: Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 2001; 10: 189-194.
5. Priori SG, Napolitano C, Memmi M et al: Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002; 106: 69-74.
6. Bauce B, Rampazzo A, Basso C et al: Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers. J Am Coll Cardiol 2002; 40: 341-349.
7. Lahat H, Eldar M, Levy-Nissenbaum E et al: Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation 2001; 103: 2822-2827.
8. Lahat H, Pras E, Olender T et al: A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 2001; 69: 1378-1384.
9. Zhang L, Kelley J, Schmeisser G, Kobayashi YM, Jones LR: Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem 1997; 272: 23389-23397.
10. Guo W, Campbell KP: Association of triadin with the ryanodine receptor and calsequestrin in the lumen of the sarcoplasmic reticulum. J Biol Chem 1995; 270: 9027-9030.
11. Tunwell RE, Wickenden C, Bertrand BM et al: The human cardiac muscle ryanodine receptor-calcium release channel: identification, primary structure and topological analysis. Biochem J 1996; 318: 477-487.
12. Bers DM: Cardiac excitation-contraction coupling. Nature 2002; 415: 198-205.
13. Slupsky JR, Ohnishi M, Carpenter MR, Reithmeier RA: Characterization of cardiac calsequestrin. Biochemistry 1987; 26: 6539-6544.
14. Swan H, Laitinen PJ: Familial polymorphic ventricular tachycardia - intracellular calcium channel disorder. Card Electrophysiol Rev 2002; 6: 81-87.
15. Syvanen AC, Aalto-Setala K, Harju L, Kontula K, Soderlund H: A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. Genomics 1990; 8: 684-692.
16. Postma AV, Denjoy I, Hoorntje TM et al: Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ Res 2002; 91: e21-e26.
17. Marx SO, Reiken S, Hisamatsu Y et al: PKA phosphorylation dissociates FKBP1.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000; 101: 365-376.
18. 2+ binding effects on protein conformation and protein interactions of canine cardiac calsequestrin. J Biol Chem 1988; 263: 1376-1381.
19. MacLennan DH, Reithmeier RA: Ion tamers. Nat Struct Biol 1998; 5: 409-411.
20. 2+ release channel of skeletal muscle sarcoplasmic reticulum (RyR1). Proc Natl Acad Sci USA 2002; 99: 16725-16730.